NCT06520878View on ClinicalTrials.gov

Impact of NANO-PSO on Cognition in Older Adults with Mild to Moderate Cognitive Impairment

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Cognition
Interventions
DIETARY_SUPPLEMENT

NANO-PSO (pomegranate seed oil)

NANO-PSO administered orally, 2 capsules, equivalent to 640 mg of pomegranate seed oil, every 24 hours in the morning with food.

DIETARY_SUPPLEMENT

Placebo

Placebo administered orally, 2 capsules, equivalent to 640 mg of mineral oil, every 24 hours in the morning with food.

Trial Locations (1)

11520

RECRUITING

Hospital Español. Av Ejercito Nacional 613, Miguel Hidalgo, CDMX, 11520, Miguel Hidalgo

All Listed Sponsors
lead

Distribuidora Biolife SA de CV

INDUSTRY